HSDT

Helius Medical Technologies Inc Class A · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website eliusmedical.com
Employees(FY) 26
ISIN US42328V8019

Performance

+70.35%

+97.96%

+10.24%

-8.63%

-88.68%

YTD

-86.83%

Profile

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of HSDT 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83, indicating robust upward momentum, while the Oscillators Score of 63 and Technical Score of 73 further reinforce this positive outlook, suggesting overall market strength and potential for continued gains.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of HSDT

Stock Rank

Recent News & Updates

2024-11-17 19:01
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS ) Device(Globenewswire)
2024-11-17 19:00
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives(Globenewswire)
2024-10-17 20:00
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference(Globenewswire)
2024-10-14 05:00
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS ) Controller and Mouthpiece(Globenewswire)
2024-09-29 20:00
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study(Globenewswire)
2024-08-16 05:00
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)(Globenewswire)
2024-08-12 04:05
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-08-06 04:36
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024(Globenewswire)
2024-06-27 18:00
7 F-Rated Growth Stocks to Avoid Right Now: June 2024(Investorplace)
2024-06-16 19:00
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke(Globenewswire)
2024-06-05 19:38
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-06-05 19:00
MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies(Accesswire)
2024-05-31 00:30
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference(Accesswire)
2024-05-28 21:00
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS from Major Insurance Carrier(Globenewswire)
2024-05-22 21:00
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS(Globenewswire)
2024-05-19 21:00
Helius Medical Technologies, Inc. Announces PoNS Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts(Globenewswire)
2024-05-13 08:53
HSDT Stock Earnings: Helius Medical Tech Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-13 04:05
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results(Globenewswire)
2024-05-09 21:00
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024(Globenewswire)
2024-05-07 19:31
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-06 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-05-06 10:15
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering(Globenewswire)
2024-05-05 21:00
Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS )(Globenewswire)
2024-05-02 20:12
Why Is Helius Medical Technology (HSDT) Stock Up 47% Today?(Investorplace)
2024-05-02 19:31
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-04-23 21:05
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center(Globenewswire)
2024-04-02 19:05
Helius Medical Technologies, Inc. Announces Partnership with Lovell Government Services to Expand Reach of PoNS Therapy(Globenewswire)
2024-04-01 00:18
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-28 04:05
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-03-14 19:05
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.